Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis

ConclusionsIn a “real world” registry, ACT compared favorably against the well‐studied SXT and MCV devices in both safety and efficacy. MCV implantation was associated with lower device success rates and higher rates of new permanent pacemaker implantation. © 2016 Wiley Periodicals, Inc.

Source: Catheterization and Cardiovascular Interventions - December 27, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Tannas Jatene, Antonio Castro ‐Filho, Rafael A. Meneguz‐Moreno, Dimytri A. Siqueira, Alexandre A.C. Abizaid, Auristela I.O. Ramos, Magaly Arrais, David C.S. Le Bihan, Rodrigo B.M. Barretto, Adriana C. Moreira, Amanda G.M.R. Sousa, J. Eduardo Sousa Tags: Valvular and Structural Heart Diseases Source Type: research